Molecular and Cellular Pathology
British Journal of Cancer (2003) 89, 1950–1957. doi:10.1038/sj.bjc.6601393 www.bjcancer.com
Published online 11 November 2003
Defects in death-inducing signalling complex formation prevent JNK activation and Fas-mediated apoptosis in DU 145 prostate carcinoma cells
1Tumour Biology Lab, Department of Biochemistry, University College Cork, Lee Maltings, Prospect Row, Cork, Ireland
Correspondence: TG Cotter, E-mail: t.cotter@ucc.ie
Received 31 March 2003; Revised 19 August 2003; Accepted 6 September 2003.
Abstract
Androgen-independent prostate carcinomas are resistant to chemotherapy and cell lines derived from androgen-independent prostate carcinomas such as DU 145 cells are highly resistant to Fas-mediated apoptosis. The incubation of DU 145 cells with anti-Fas IgM agonistic antibody of Fas receptor fails to activate JNK, a stress kinase involved in regulating apoptosis. We have previously shown that JNK activation is sufficient and necessary to promote Fas-mediated apoptosis in DU 145 cells. We investigate the mechanisms by which JNK activation and apoptosis are abrogated. HSP27 is overexpressed in DU 145 cells and has previously been reported to sequester DAXX and prevent JNK activation in cells treated with anti-Fas IgM. However, we find no evidence that HSP27 interacts with DAXX in DU 145 cells. Instead, we find that FADD does not interact with caspase-8 and this results in defective death-inducing signalling complex formation following Fas receptor activation.
Keywords:
CD95, apoptosis, FADD, DAXX, HSP27, JNK
